Mc Collum Christoferson Group LLC Abb Vie Inc. Transaction History
Mc Collum Christoferson Group LLC
- $327 Million
- Q4 2025
A detailed history of Mc Collum Christoferson Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mc Collum Christoferson Group LLC holds 950 shares of ABBV stock, worth $222,300. This represents 0.07% of its overall portfolio holdings.
Number of Shares
950
Previous 950
-0.0%
Holding current value
$222,300
Previous $219,000
1.37%
% of portfolio
0.07%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
4,544Shares Held
1.28BCall Options Held
16.9MPut Options Held
15.4M-
Vanguard Group Inc Valley Forge, PA181MShares$42.3 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...